Trinseo (NYSE: TSE), a global materials solutions provider and manufacturer of plastics, latex binders and synthetic rubber, will promote its resins for drug delivery devices at two events this week: MD&M West in Anaheim, California at Booth 1952 from February 6 – 8, 2018 and at Pharmapack in Paris at Hall F.1 Stand G13 from February 7 – 8, 2018.
As the medical industry continues to innovate and bring life enhancing devices to market, self-administered therapies are becoming commonplace. Trinseo supports this growth trend by offering materials to medical devices and pharmaceutical manufacturers that enable performance, functionality, usability, and aesthetics.
Trinseo’s specialty compounded solutions are used for an array of applications including:
Other applications include auto injectors, insulin pens, inhalers, prefilled syringes, and wearable devices.
Trinseo has been supporting the medical devices industry for nearly 30 years and, with its ISO 13485 certification, is recognized for its strong commitment to quality and customer compliance requirements.
Because of its recent acquisition of API, Trinseo now offers a strong portfolio of soft-touch polymers to complement its rigid performance plastics. Soft touch polymers are well suited for drug delivery devices in areas such as soft-touch grips and drip chamber applications.
Contact Paula Biskup to arrange a time to meet at either show.
Trinseo (NYSE: TSE) is a global materials solutions provider and manufacturer of plastics, latex binders, and synthetic rubber. We are focused on delivering innovative and sustainable solutions to help our customers create products that touch lives every day — products that are intrinsic to how we live our lives — across a wide range of end-markets, including automotive, appliances, consumer electronics, medical devices, electrical, building and construction, textiles, paper and board, footwear and tires. Trinseo had approximately $4.4 billion in net sales in 2017, with 16 manufacturing sites around the world, and approximately 2,200 employees. For more information visit www.trinseo.com
This press release may contain “forward-looking statements” including, without limitation, statements concerning plans, objectives, goals, projections, expectations, strategies, future events or performance, and underlying assumptions and other statements, which are not statements of historical facts. Forward-looking statements may be identified by the use of words like “expect,” “estimate,” “will,” “may,” or expressions of similar meaning. Forward-looking statements reflect management’s evaluation of information currently available and are based on the Company’s current expectations and assumptions regarding the impact from the COVID-19 pandemic, the Company’s business, the economy and other future conditions. Specific factors that could cause future results to differ from those expressed by the forward-looking statements include, but are not limited to, risks related to the ongoing impact of the COVID-19 pandemic and those discussed in the Company’s Annual Report for the year ended December 31, 2019 filed with the Securities and Exchange Commission (“SEC”), in subsequent Quarterly Reports on Form 10-Q and in other filings and furnishings made by the Company with the SEC from time to time. Other unknown or unpredictable factors could also have material adverse effects on the Company’s performance. As a result of these or other factors, the Company’s actual results may differ materially from those contemplated by the forward-looking statements. The forward-looking statements included in this press release are made only as of the date hereof and are not a guarantee of future performance. The Company undertakes no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.